РЕЙД, Джульет (GB),САДДИК, Джордж (US),ЗАМУНЕР, Стефано (GB),ЦЕККИН, Кьяра (GB)
申请号：
RU2019108441
公开号：
RU2019108441A
申请日:
2017.08.29
申请国别(地区):
RU
年份:
2020
代理人:
摘要：
The present invention provides pharmaceutical compositions comprising antigen binding proteins that specifically bind Oncostatin M (OSM) and in particular human OSM (hOSM) and which inhibit the binding of OSM to the gp130 receptor,novel therapeutic regimens for said pharmaceutical compositions； and methods for administering said pharmaceutical compositions in the treatment of an inflammatory or autoimmune disorder, in particular in the treatment of systemic sclerosis.
